Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence

FASEB Journal

Volumn 26, Issue 1, 2012, Pages 460-467

  Morin, Aurélie ^a   Fritsch, Lauriane ^a   Mathieu, Jacques R R ^a   Gilbert, Cristèle ^a   Guarmit, Basma ^b   Firlej, Virginie ^a   Gallou Kabani, Catherine ^c   Vieillefond, Annick ^d   Delongchamps, Nicolas Barry ^a,d   Cabon, Florence ^a,c  

^a CNRS   (France)

^b INSERM   (France)

^c SeleXel   (France)

^d SeleXel ^*  (France)

Author keywords

Nuclear translocation; Pyrimidine biosynthesis

Indexed keywords

ANDROGEN RECEPTOR; ASPARTATE CARBAMOYLTRANSFERASE; CARBAMOYL PHOSPHATE SYNTHASE (GLUTAMINE HYDROLYSING); DIHYDROOROTASE; MESSENGER RNA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RECURRENCE; CANCER RELAPSE; CELL STRAIN LNCAP; CLINICAL ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PYRIMIDINE SYNTHESIS; TUMOR XENOGRAFT;

ANDROGENS; ANIMALS; ASPARTATE CARBAMOYLTRANSFERASE; CARBAMOYL-PHOSPHATE SYNTHASE (GLUTAMINE-HYDROLYZING); CELL LINE, TUMOR; CELL NUCLEUS; CYTOSOL; DIHYDROOROTASE; HUMANS; MALE; MICE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; PYRIMIDINES; RECEPTORS, ANDROGEN; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

MUS;

EID: 84855364968     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-191296     Document Type: Article

References (25)

1. Heinlein, C. A., and Chang, C. (2004) Androgen receptor in prostate cancer. Endocr. Rev. 25, 276-308 (Pubitemid 38501396)
2. Knudsen, K. E., and Penning, T. M. (2010) Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer. Trends Endocrinol Metab. 21, 315-324
3. Chi, K. N., Bjartell, A., Dearnaley, D., Saad, F., Schroder, F. H., Sternberg, C., Tombal, B., and Visakorpi, T. (2009) Castration-resistant prostate cancer: from new pathophysiology to new treatment targets. Eur. Urol. 56, 594-605
4. Linja, M. J., Porkka, K. P., Kang, Z., Savinainen, K. J., Janne, O. A., Tammela, T. L., Vessella, R. L., Palvimo, J. J., Visakorpi, T., Mohler, J. L., Gregory, C. W., Ford, O. H., III, Kim, D., Weaver, C. M., Petrusz, P., Wilson, E. M., and French, F. S. (2004) Expression of androgen receptor coregulators in prostate cancer. The androgen axis in recurrent prostate cancer. Clin. Cancer Res. 10, 1032-1040 (Pubitemid 38202234)
5. Bettoun, D. J., Scafonas, A., Rutledge, S. J., Hodor, P., Chen, O., Gambone, C., Vogel, R., McElwee-Witmer, S., Bai, C., Freedman, L. P., and Schmidt, A. (2005) Interaction between the androgen receptor and RNaseL mediates a crosstalk between the interferon and androgen signaling pathways. J. Biol. Chem. C500324200
6. Miyamoto, H., Yeh, S., Wilding, G., and Chang, C. (1998) Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proc. Natl. Acad. Sci. U. S. A. 95, 7379-7384 (Pubitemid 28293260)
7. Culig, Z., Steiner, H., Bartsch, G., and Hobisch, A. (2005) Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours. Endocr. Relat. Cancer 12, 229-244 (Pubitemid 40896443)
8. Heemers, H. V., Regan, K. M., Schmidt, L. J., Anderson, S. K., Ballman, K. V., and Tindall, D. J. (2009) Androgen modulation of coregulator expression in prostate cancer cells. Mol. Endocrinol. 23, 572-583
9. Coleman, P. F., Suttle, D. P., and Stark, G. R. (1977) Purification from hamster cells of the multifunctional protein that initiates de novo synthesis of pyrimidine nucleotides. J. Biol. Chem. 252, 6379-6385 (Pubitemid 8193781)
10. Sigoillot, F. D., Kotsis, D. H., Serre, V., Sigoillot, S. M., Evans, D. R., and Guy, H. I. (2005) Nuclear localization and mitogen-activated protein kinase phosphorylation of the multifunctional protein CAD. J. Biol. Chem. 280, 25611-25620 (Pubitemid 40962269)
11. Karle, J. M., Anderson, L. W., and Cysyk, R. L. (1984) Effect of plasma concentrations of uridine on pyrimidine biosynthesis in cultured L1210 cells. J. Biol. Chem. 259, 67-72 (Pubitemid 14177634)
12. Tessera, L., Mucciolo, E., Bertoni, L., and Giulotto, E. (1995) Selection of N-(phosphonacetyl)-L-aspartate resistant Chinese hamster mutants in the presence of the uridine uptake inhibitor dipyridamole. Anticancer Res. 15, 189-192
13. Sigoillot, F. D., Sigoillot, S. M., and Guy, H. I. (2004) Breakdown of the regulatory control of pyrimidine biosynthesis in human breast cancer cells. Int. J. Cancer 109, 491-498 (Pubitemid 38339638)
14. Khan, S., Abdelrahim, M., Samudio, I., and Safe, S. (2003) Estrogen receptor/sp1 complexes are required for induction of cad gene expression by 17β-estradiol in breast cancer cells. Endocrinology 144, 2325-2335 (Pubitemid 36629884)
15. Reardon, M. A., Dixon, J. E., and Weber, G. (1987) Increased messenger RNA concentration for carbamoyl-phosphate synthase II in hepatoma 3924A. Biochem. Biophys. Res. Commun. 147, 494-500
16. Tlsty, T. D., Margolin, B. H., and Lum, K. (1989) Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis. Proc. Natl. Acad. Sci. U. S. A. 86, 9441-9445 (Pubitemid 20010442)
17. Colombel, M., Filleur, S., Fournier, P., Merle, C., Guglielmi, J., Courtin, A., Degeorges, A., Serre, C. M., Bouvier, R., Clezardin, P., and Cabon, F. (2005) Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate. Cancer Res. 65, 300-308 (Pubitemid 40070822)
18. Nakatani, Y., and Ogryzko, V. (2003) Immunoaffinity purification of mammalian protein complexes. Methods Enzymol. 370, 430-444 (Pubitemid 37542800)
19. Ameyar-Zazoua, M., Souidi, M., Fritsch, L., Robin, P., Thomas, A., Hamiche, A., Percipalle, P., Ait-Si-Ali, S., and Harel-Bellan, A. (2009) Physical and functional interaction between heterochromatin protein 1alpha and the RNA-binding protein heterogeneous nuclear ribonucleoprotein U. J. Biol. Chem. 284, 27974-27979
20. Sramkoski, R. M., Pretlow, T. G., 2nd, Giaconia, J. M., Pretlow, T. P., Schwartz, S., Sy, M. S., Marengo, S. R., Rhim, J. S., Zhang, D., and Jacobberger, J. W. (1999) A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell. Dev. Biol. Anim. 35, 403-409 (Pubitemid 29380004)
21. Brizova, H., Kalinova, M., Krskova, L., Mrhalova, M., and Kodet, R. (2010) A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase IIalpha, and TPX2): an immunohistochemical correlation, testing, and optimizing for mantle cell lymphoma. Virchows Arch. 456, 671-679
22. Chaparian, M., and Evans, D. (1988) Intracellular location of the multidomain protein CAD in mammalian cells. FASEB J. 2, 2982-2989 (Pubitemid 18261416)
23. Qiu, Y.-Q., Leuschner, I., and Braun, P. M. (2008) Androgen receptor expression in clinically localized prostate cancer: immunohistochemistry study and literature review. Asian J. Androl. 10, 855-863
24. Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., and Sawyers, C. L. (2004) Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10, 33-39 (Pubitemid 38524696)
25. Borley, N., and Feneley, M. R. (2008) Prostate cancer: diagnosis and staging. Asian J. Androl. 11, 74-80